UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas

The New England journal of medicine, 2016-12, Vol.375 (26), p.2550-2560

2016

Volltextzugriff (PDF)

High-Intensity Focused Ultrasound (HIFU) Triggers Immune Sensitization of Refractory Murine Neuroblastoma to Checkpoint Inhibitor Therapy

Clinical cancer research, 2020-03, Vol.26 (5), p.1152-1161

2020

Volltextzugriff (PDF)

Current Treatment Options for Malignant Peripheral Nerve Sheath Tumors

Current treatment options in oncology, 2015-03, Vol.16 (3), p.328-328, Article 12

2015

Volltextzugriff (PDF)

Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future

JNCI : Journal of the National Cancer Institute, 2017-08, Vol.109 (8)

2017

Volltextzugriff (PDF)

Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia

Clinical cancer research, 2012-04, Vol.18 (7), p.2099-2107

2012

Volltextzugriff (PDF)

Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies

Sarcoma, 2017, Vol.2017, p.7429697-10

2017

Volltextzugriff (PDF)

Glucarpidase, Leucovorin, and Thymidine for High-Dose Methotrexate-Induced Renal Dysfunction: Clinical and Pharmacologic Factors Affecting Outcome

Journal of clinical oncology, 2010-09, Vol.28 (25), p.3979-3986

2010

Volltextzugriff (PDF)

Boiling histotripsy lesion characterization on a clinical magnetic resonance imaging-guided high intensity focused ultrasound system

PloS one, 2017-03, Vol.12 (3), p.e0173867-e0173867

2017

Volltextzugriff (PDF)

Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)

Sarcoma, 2020, Vol.2020, p.5784876-8

2020

Volltextzugriff (PDF)

Preclincial testing of Sorafenib and RAD001 in the Nfflox/flox;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging

Pediatric blood & cancer, 2012-02, Vol.58 (2), p.173-180

2012

Volltextzugriff (PDF)

Feasibility of magnetic resonance-guided high-intensity focused ultrasound treatment targeting distinct nodular lesions in neurofibromatosis type 1

Neuro-oncology advances, 2021-01, Vol.3 (1), p.vdab116-vdab116

2021

Volltextzugriff (PDF)

Histopathologic Evaluation of Atypical Neurofibromatous Tumors and Their Transformation into Malignant Peripheral Nerve Sheath Tumor in Neurofibromatosis 1 Patients – A Consensus Overview

Human pathology, 2017-05, Vol.67, p.1-10

2017

Volltextzugriff (PDF)

DEI-04. RACE AND ETHNICITY DIFFERENCES IN TREATMENT-LIMITING TOXICITIES IN PATIENTS TREATED WITH MEK INHIBITORS

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

Recurrent Immature Teratoma

Journal of pediatric & adolescent gynecology, 2022-04, Vol.35 (2), p.215-215

2022

Volltextzugriff (PDF)

Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1—a consensus overview

Human pathology, 2017-09, Vol.67, p.1-10

2017

Volltextzugriff (PDF)

Selumetinib in Children with Inoperable Plexiform Neurofibromas

The New England journal of medicine, 2020-04, Vol.382 (15), p.1430-1442

2020

Volltextzugriff (PDF)

Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use

Neurology, 2021-08, Vol.97 (7 Suppl 1), p.S91

2021

Volltextzugriff (PDF)

The need for new treatments targeting MPNST: the potential of strategies combining MEK inhibitors with antiangiogenic agents

Clinical cancer research, 2022-08, Vol.28 (15), p.3185-3195

2022

Volltextzugriff (PDF)

Abstract 1700: Immune effects of high intensity focused ultrasound ablation with checkpoint inhibitors in murine neuroblastoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1700-1700

2021

Volltextzugriff (PDF)

Emerging hyperthermia applications for pediatric oncology

Advanced drug delivery reviews, 2020, Vol.163-164, p.157-167

2020

Volltextzugriff (PDF)

The promise of signal transduction in genetically driven sarcomas of the nerve

Experimental neurology, 2018-01, Vol.299 (Pt B), p.317-325

2018

Volltextzugriff (PDF)

Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward

Journal of clinical oncology, 2016-09, Vol.34 (25), p.3031-3038

2016

Volltextzugriff (PDF)

Focused Ultrasound for Pediatric Diseases

Pediatrics (Evanston), 2022-03, Vol.149 (3), p.1

2022

Volltextzugriff (PDF)

Outcome of patients with refractory malignant peripheral nerve sheath tumors (MPNST) enrolled on phase 2 trials

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e22534-e22534

2019

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Englisch
(102)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(52)
Humans
(41)
Oncology
(39)
Child
(30)
Male
(23)
Female
(22)
Adolescent
(21)
Pediatrics
(18)
Child, Preschool
(16)
Tumors
(16)
Young Adult
(10)
Adult
(9)
Antineoplastic Agents - Pharmacokinetics
(9)
Neurofibromatosis Type 1
(9)
Animals
(8)
Cancer
(8)
Children
(8)
Hematology
(8)
Magnetic Resonance Imaging
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas

High-Intensity Focused Ultrasound (HIFU) Triggers Immune Sensitization of Refractory Murine Neuroblastoma to Checkpoint Inhibitor Therapy

Current Treatment Options for Malignant Peripheral Nerve Sheath Tumors

Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future

Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia

Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies

Glucarpidase, Leucovorin, and Thymidine for High-Dose Methotrexate-Induced Renal Dysfunction: Clinical and Pharmacologic Factors Affecting Outcome

Boiling histotripsy lesion characterization on a clinical magnetic resonance imaging-guided high intensity focused ultrasound system

Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)

Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016)

Preclincial testing of Sorafenib and RAD001 in the Nfflox/flox;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging

Feasibility of magnetic resonance-guided high-intensity focused ultrasound treatment targeting distinct nodular lesions in neurofibromatosis type 1

Histopathologic Evaluation of Atypical Neurofibromatous Tumors and Their Transformation into Malignant Peripheral Nerve Sheath Tumor in Neurofibromatosis 1 Patients – A Consensus Overview

DEI-04. RACE AND ETHNICITY DIFFERENCES IN TREATMENT-LIMITING TOXICITIES IN PATIENTS TREATED WITH MEK INHIBITORS

Recurrent Immature Teratoma

Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1—a consensus overview

Selumetinib in Children with Inoperable Plexiform Neurofibromas

Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use

The need for new treatments targeting MPNST: the potential of strategies combining MEK inhibitors with antiangiogenic agents

Abstract 1700: Immune effects of high intensity focused ultrasound ablation with checkpoint inhibitors in murine neuroblastoma

Emerging hyperthermia applications for pediatric oncology

The promise of signal transduction in genetically driven sarcomas of the nerve

Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward

Focused Ultrasound for Pediatric Diseases

Outcome of patients with refractory malignant peripheral nerve sheath tumors (MPNST) enrolled on phase 2 trials

Suchergebnisse filtern